Move to www.1688club.com now,This Website will be closed
SearchSearch

Orlistat CAS:*-58-2

ID:561363 View:1435 Collection
Date Listed: 2018-05-25 09:13:43 Country: China»Jiangsu»Suzhou
Poster: Morgana Watson Company: JIANGSU WATSON BIOTECHNOLOGY CO.,LTD
Location: Jinfeng international community, Jinfeng Road, High-tech Zone Website: JIANGSU WATSON BIOTECHNOLOGY CO.,LTD
Email: sale8@ws-biology.com Mobile: 15072758944
Fax: MSN:

Orlistat CAS:*-58-2 Hello,dear friend,don't hesitate to contact us,we are sure to be your best supplier! Skype:live:sale8_120 Email:*ology.com Twitter:Lill*nSale8 Product Description Wholesale Price of Orlistat Powder Dosage and Effect CAS:*-58-2 Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet. Orlistat Basic Info. Product Name: Orlistat CAS: *-58-2 MF: C29H53NO5 MW: 495.73 Appearance: White Powder Chemical Properties: mp: <50 °C storage temp: 2-8°C solubility DMSO: 19 mg/mL appearance: Off-White Solid Orlistat Usage: 1. An antiobesity agent. A pancreatic lipase inhibitor. Antiobesity agent. 2. antidiabetic 3. Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor. 4. Tetrahydrolipstatin (orlistat) is a semi-synthetic derivative of lipstatin, a metabolite isolated from Streptomyces toxytricini. Tetrahydrolipstatin acts as a potent, irreversible inhibitor of pancreatic lipase. In vivo, it blocks the absorption of triglycerides while allowing fatty acid absorption. Tetrahydrolipstatin is widely used for the treatment of obesity. 5. Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost. 6. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-

Please Note that this information was issued on BestB2B.com!

High Quality TC TG TB Oil Seal NBR FKM ACM VMQ Oil2024-02-03

costa rica liquid nitrogen sample storage tank 2024-02-02

NQKSF Oil Seal Brand New High Quality FKM Seals2024-02-01

Syria nitrogen semen tank KGSQ five-wheeled cart2024-01-31

Honduras large diameter liquid nitrogen container2024-01-29

Wholesale Good Quality NQK O Ring Seals2024-01-29

Charging market environment continues to evolve2024-01-29

EVs High Voltage Cable Development Thread2024-01-29

China supply Support ring FK4E39-K for power plant2024-01-29

Lock nutboiler feedwater pump HPT200-330M for powe2024-01-29

China Manufacturer Respirator DG600-240-05-15-00 f2024-01-29

China made Hu bevel gear 0130/0010/0140 for steam 2024-01-29

Liquid-cooled cables for EV high-power charging2024-01-29

EV High Voltage Cable Connection Differences2024-01-29

Made In China Gearbox Seals Dustproof Oil Seal2024-01-26

Important Safety Warning: Avoid fraud by meeting all sellers in-person to pay for items. BestB2B.COM does not offer any transaction or payment services.